0.0580USD+1.93%Mkt Cap: —P/E: —2d ago
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company of…
Industry Peers
Health Care Equipment & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)587.24M $
Gross Profit92.17M $
Net Income (TTM)-30.56M $
Revenue/Share5.814 USD
Last Price0.0580 USD
Fiscal Year End—
MR Quarter—
Employees641
CountryUS
SectorHealthcare
IndustryHealth Care Equipment & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.36
EPS (TTM)—
EPS (Forward)—
52W Range
0.049882% of range0.0598
52W High0.0598 USD
52W Low0.0498 USD
Profitability
Gross Margin15.69%
Oper. Margin-2.86%
EBITDA Margin-3.28%
Profit Margin-6.18%
ROE—
ROA-9.65%
Growth
Revenue Growth34.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF328.00K $
CapEx (TTM)—
FCF Margin1.46%
FCF Yield—
Net Debt63.70M $
Net Debt/EBITDA-3.30
Balance Sheet
Debt/Equity—
Current Ratio1.36
Quick Ratio1.14
Book Value/Sh-0.1630 USD
Cash/Share0.4030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float88.59M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta0.42
S&P 52W Chg18.16%
Avg Vol (30d)8.32K
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—